Reuters logo
BRIEF-Sangui Biotech International announces start of preclinical trials to certify an oxygen carrier as a Class III medical product
August 6, 2014 / 1:05 PM / 3 years ago

BRIEF-Sangui Biotech International announces start of preclinical trials to certify an oxygen carrier as a Class III medical product

Aug 6 (Reuters) - Sangui Biotech International Inc : * Says start of preclinical trials to certify an oxygen carrier as a Class III medical product Source text for Eikon * Further company coverage

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below